Amphastar Pharmaceuticals, Inc. - Common Stock (NQ:AMPH)
Price and Volume
Detailed Quote| Volume | 629,722 |
| Open | 18.97 |
| Bid (Size) | 19.19 (1,000) |
| Ask (Size) | 19.21 (100) |
| Prev. Close | 19.34 |
| Today's Range | 18.52 - 19.37 |
| 52wk Range | 18.93 - 31.26 |
| Shares Outstanding | 48,081,433 |
| Dividend Yield | N/A |
Top News
More News
Performance
| YTD |
-27.4%
|
-27.4%
|
| 1 Month |
-34.3%
|
-34.3%
|
| 3 Month |
-26.1%
|
-26.1%
|
| 6 Month |
-34.3%
|
-34.3%
|
| 1 Year |
-32.4%
|
-32.4%
|
More News
Read More
Why Amphastar Pharmaceuticals (AMPH) Shares Are Plunging Today
February 27, 2026
Via StockStory
Topics
Economy
Amphastar (AMPH) Q4 2025 Earnings Call Transcript ↗
February 26, 2026
Via The Motley Fool
Wondering what's happening in today's after-hours session? ↗
February 26, 2026
Via Chartmill
Via StockStory
Topics
Artificial Intelligence
Amphastar Announces FDA Approval for Ipratropium Bromide HFA
February 24, 2026
Via ACCESS Newswire
1 Value Stock on Our Watchlist and 2 We Turn Down
February 15, 2026
Via StockStory
Topics
Retirement
Amphastar Pharmaceuticals, Novavax, and Organon Shares Skyrocket, What You Need To Know
February 13, 2026
Via StockStory
Topics
Economy
3 Cash-Producing Stocks We Keep Off Our Radar
February 09, 2026
Via StockStory
3 Stocks Under $50 with Warning Signs
February 04, 2026
Via StockStory
Topics
Artificial Intelligence
Why Amphastar Pharmaceuticals (AMPH) Stock Is Nosediving
January 15, 2026
Via StockStory
2 Reasons to Avoid AMPH and 1 Stock to Buy Instead
January 14, 2026
Via StockStory
1 Profitable Stock Worth Your Attention and 2 Facing Headwinds
January 13, 2026
Via StockStory
Why Amphastar Pharmaceuticals (AMPH) Stock Is Trading Up Today
January 12, 2026
Via StockStory
3 Low-Volatility Stocks We Find Risky
January 07, 2026
Via StockStory
Amphastar Director Sells 16,679 Shares for $441,800 ↗
December 23, 2025
Via The Motley Fool
Topics
Regulatory Compliance
3 Healthcare Stocks with Questionable Fundamentals
December 15, 2025
Via StockStory
Topics
Stocks
Amphastar Announces FDA Approval for Teriparatide Injection
December 15, 2025
Via ACCESS Newswire
Frequently Asked Questions
Is Amphastar Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, Amphastar Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does Amphastar Pharmaceuticals, Inc. - Common Stock trade on?
Amphastar Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Amphastar Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for Amphastar Pharmaceuticals, Inc. - Common Stock is AMPH on the Nasdaq Stock Market
What is the current price of Amphastar Pharmaceuticals, Inc. - Common Stock?
The current price of Amphastar Pharmaceuticals, Inc. - Common Stock is 19.21
When was Amphastar Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of Amphastar Pharmaceuticals, Inc. - Common Stock was at 03/09/26 04:00 PM ET
What is the market capitalization of Amphastar Pharmaceuticals, Inc. - Common Stock?
The market capitalization of Amphastar Pharmaceuticals, Inc. - Common Stock is 923.64M
How many shares of Amphastar Pharmaceuticals, Inc. - Common Stock are outstanding?
Amphastar Pharmaceuticals, Inc. - Common Stock has 924M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
>